glp 1 receptor function GLP-1 agonists for individualized treatment of type 2 diabetes mellitus GLP-1 receptor agonists | How

This study was sponsored by ProGen Co., Ltd., which was involved in the study design, data collection, data analysis, and manuscript preparation

Interested researchers, wishing to access individual phenotypic data would need to submit argued applications to the relevant National Data Protection Agencies

In addition, psychological and behavioural factors contributing to AAS useincluding muscle dysmorphia, social pressure, and body-image concernsare discussed as important modulators of risk

10.1016/j.molmed.2021.01.005 167 OrningP.WengD.StarheimK.RatnerD.BestZ.LeeB.et al (2018)

Esta ingesta debe individualizarse segn actividad fsica, clima y condiciones mdicas